ALDA Receives Delivery of New T36(R) Antiseptic Hand Sanitizer

Welcome to the ALDA Pharmaceuticals Hub on AGORACOM

(Edit this message through the "fast facts" section)

ATTENTION MEMBERS:

Tonight, we're giving our website a serious makeover.

So if you can't access the site for a bit, don't worry, we're just sprucing things up for an even smoother experience.

In the event that you experience issues accessing the new site, please clear your browser's cookies and cache.

See You On The Other Side!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

woodstock135

Rank: Treasurer [?]

Points: 875 [?]

Votes: 59 Score: 2.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

ALDA Receives Delivery of New T36(R) Antiseptic Hand Sanitizer

posted on Dec 10, 2008 08:54AM

ALDA Receives Delivery of New T36(R) Antiseptic Hand Sanitizer

VANCOUVER, BRITISH COLUMBIA, Dec 10, 2008 (Marketwire via COMTEX News Network) --

ALDA Pharmaceuticals Corp. (TSX VENTURE:APH) ("the Company" or "ALDA") announces that its T36(R) Antiseptic Hand Sanitizer Gel (DIN 02314320), the first ALDA product that has been approved for human use by Health Canada, has been manufactured and delivered, and is now ready to be shipped to distributors.

Compared to typical alcohol-based hand sanitizers, ALDA's T36(R) Antiseptic Hand Sanitizer is a unique formula with two active ingredients that provide faster action against a broader range of infectious organisms and offer a long-lasting residual effect.

Group 270 Sales & Marketing Inc. ("Group 270"), ALDA's marketing agent, will be introducing T36(R) Antiseptic Hand Sanitizer to major regional and national pharmacy chains across Canada. The Company's current distributors will also be providing this new product to their customers. Other marketing activities are being initiated that are designed to penetrate additional market sectors not currently serviced by the Company.

About ALDA Pharmaceuticals

ALDA is focused on the development of infection-control therapeutics derived from its patented T36(R) technology. The company trades on the TSX Venture Exchange under the symbol APH.

Terrance G. Owen, Ph.D., MBA, President & CEO

ALDA Pharmaceuticals Corp.

SOURCE: ALDA Pharmaceuticals Corp.

ALDA Pharmaceuticals Corp. Peter Chen Distribution & Sales Contact (604) 521- 8300 Ext. 3 (604) 521-8322 (FAX) Email: [email protected] ALDA Pharmaceuticals Corp. Scott Young Investor Relations Contact (604) 288-7222 Email: [email protected] Website: www.aldacorp.com